The most extensive examination of prenatal screening for cystic fibrosis (CF) to date revealed that the UNITY Fetal Risk™ Screen successfully detected every CF case within the study group. Taking place in Menlo Park, California, the study was conducted on September 15, 2025. BillionToOne, Inc., a molecular diagnostics firm, spearheaded this effort, aiming to develop robust and precise tests for medical purposes.